EGFR CLINICAL EVIDENCE

Peer Reviewed Publications

Longitudinal Monitoring of ctDNA EGFR Mutation Burden from Urine Correlates with Patient Response to EGFR TKIs: A Case Series

2017 | Lung Cancer Journal

Non‑Invasive Urine Testing of EGFR Activating Mutation and T790M Resistance Mutation in Non‑Small Cell Lung Cancer

2016 | Experimental Hematology & Oncology

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations In Urine and Plasma

2016 | Journal of Thoracic Oncology

Scientific Conference Proceedings

Longitudinal Monitoring of ctDNA EGFR Mutation Burden from Urine Correlates with Patient Response to EGFR Tyrosine Kinase Inhibitors: A Case Series

2016 | International Association for the Study of Lung Cancer- World Conference on Lung Cancer

Urine Detection of EGFR T790M Mutation in Non-Small-Cell Lung Cancer:
An Outcomes and Total Cost of Care Analysis

2016 | International Association for the Study of Lung Cancer- World Conference on Lung Cancer

Dynamics of EGFR Mutational Load in Urine and Plasma Correlates with
Treatment Response in Advanced NSCLC

2016 | International Association for the Study of Lung Cancer- World Conference on Lung Cancer

Assessment of EGFR Mutations in Matched Urine, Plasma and Tumor Tissue in NSCLC Patients Treated with Rociletinib (CO-1686)

2015 | AACR- NCI- EORTC

Kinetic Monitoring of EGFR Exon 19 del L858R and T790M in Urinary ctDNA Predicts Radiologic Progression and Response in Patients with Metastatic Lung Adenocarcinoma

2015 | American Society of Clinical Oncology

Methodology for Single Copy Detection and Quantitative Monitoring of Clinically Actionable Circulating Tumor DNA Mutations in Urine from Cancer Patients

2015 | American Association for Cancer Research